No insider open-market trades in 90 days (SEC Form 4). Congress: net selling of $15K to $50K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Qube Research
$129.5M
added
Citadel
$71.3M
added
Sells/Trims (1)
Tremblant Capital
$50.7M
sold
No tracked top-trader positions in ROL as of Oct 24, 10:57 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Oct 21, 2026
Period ending
Sep 30, 2026
Earnings per share
$0.34 expected
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 21, 2026 | $0.34 / $0.34Yahoo Finance | -1.41% miss | $1.09B No estimateSEC filing | Unavailable |
| Jun 30, 2026 | Jul 22, 2026 | $0.32 / $0.34Yahoo Finance | -5.82% miss | $1.08B No estimateSEC filing | Unavailable |
| Mar 31, 2026 | Apr 22, 2026 | $0.24 / $0.24Yahoo Finance | +1.32% beat | $906.4M No estimate | Unavailable |
| Dec 31, 2025 | Feb 11, 2026 | $0.25 / $0.27Yahoo Finance | -6.64% miss | $912.9M No estimate | Unavailable |
| Sep 30, 2025 | Oct 29, 2025 | $0.35 / $0.33Alpha Vantage | +6.06% beat | $1.03B No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 23, 2025 | $0.30 / $0.30Alpha Vantage | +0.00% in line | $999.5M No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 23, 2025 | $0.22 / $0.22Alpha Vantage | +0.00% in line | $822.5M No estimate | Unavailable |
| Dec 31, 2024 | Feb 12, 2025 | $0.23 / $0.23Alpha Vantage | -0.78% in line | $832.2M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.03B | $912.9M | $906.4M | $1.08B |
| Cost of what it sold | $467.4M | $479.1M | $445.5M | $508.6M |
| Gross profit | $558.7M | $433.8M | $460.9M | $569.9M |
| What it spent | ||||
| Sales and admin | $301.4M | $273.7M | $282.9M | $183.0M |
| Other operating costs | $32.2M | — | $32.5M | $185.6M |
| Total operating expenses | $333.6M | $272.6M | $315.4M | $368.6M |
| What was left | ||||
| Operating profit | $225.0M | $161.2M | $145.5M | $201.4M |
| Interest on debt | $7.9M | $7.4M | $8.9M | $9.4M |
| Profit before tax | $217.4M | $154.7M | $137.1M | $189.8M |
| Tax | $53.9M | $38.3M | $29.3M | $45.8M |
| Net profit | $163.5M | $116.4M | $107.8M | $143.9M |
| EBITDA | $257.6M | $193.7M | $178.4M | $232.8M |
This stock is trending upward, and looks overbought after a fast run-up.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bearish
FactSet Research Systems Inc. (FDS) Stock forecasts
NeutralOct 23Honeywell International Inc. (HON) Stock forecasts
NeutralOct 23Rollins, Inc. Estimates – NYSE:ROL
NeutralOct 23Rollins, Inc. Estimates – TRADEGATE:RLS
NeutralOct 23FactSet Research Systems Inc. (FDS) Stock forecasts
NeutralOct 23Mettler-Toledo International, I (MTD) Stock Forecasts
NeutralOct 23ResMed Inc. (RMD) Stock forecasts
NeutralOct 23Rollins 2026: Revenue $1.09B, Net income $157.93M, EPS $0.33— 10-Q Summary
Leans bearishOct 2232 macro signals shaping ROL right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results